{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:09:04Z","timestamp":1780538944653,"version":"3.54.1"},"reference-count":51,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) presents unique treatment challenges, often due to the development of anti-cancer drug resistance. Previously, we demonstrated that CRISPR-directed gene ablation disabled the master regulator gene NRF2, a transcription factor known to control drug resistance in squamous cell carcinoma tumor cells, and restored chemosensitivity. In this short study, we evaluated a broad range of CRISPR\/Cas9 molecules for their capacity to elicit similar responses in PDAC cells. Synthetic single guide RNAs (sgRNAs) were designed to target multiple functional domains encoded by NRF2. These molecules were delivered to cells via nucleofection, with outcomes analyzed by genotypic, phenotypic, and functional assays. We observed targeting efficiencies ranging from 25% to 100% with a high level of random insertions and deletions (indels). sgRNAs targeting exons 2, 3 and 4 demonstrated a high degree of genotypic, phenotypic and functional outcomes. Targeted disruption of exons 3 and 4 reveals significant loss of cell viability while overcoming drug resistance through the restoration of sensitivity to gemcitabine (&gt;1.75 \u03bcM). Our study identifies domain-specific sites within NRF2 that, when disabled, restore sensitivity to gemcitabine, potentiating a more in-depth analysis of this novel augmentative therapeutic approach.<\/jats:p>","DOI":"10.3390\/biom16060828","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:08:02Z","timestamp":1780535282000},"page":"828","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genotypic and Phenotypic Diversity as a Function of CRISPR-Directed Gene Knock-Out of NRF2 in Pancreatic Adenocarcinoma Cells, a Feasibility Study"],"prefix":"10.3390","volume":"16","author":[{"given":"London P.","family":"McGill","sequence":"first","affiliation":[{"name":"Gene Editing Institute, ChristianaCare, Newark, DE 19713, USA"},{"name":"Department of Medical and Molecular Sciences, University of Delaware, Newark, DE 19713, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-9460","authenticated-orcid":false,"given":"Kelly H.","family":"Banas","sequence":"additional","affiliation":[{"name":"Gene Editing Institute, ChristianaCare, Newark, DE 19713, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-1551","authenticated-orcid":false,"given":"Gregory","family":"Tiesi","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, HMH Jersey Shore University Medical Center, Neptune, NJ 07753, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-5325","authenticated-orcid":false,"given":"Eric B.","family":"Kmiec","sequence":"additional","affiliation":[{"name":"Gene Editing Institute, ChristianaCare, Newark, DE 19713, USA"},{"name":"Department of Medical and Molecular Sciences, University of Delaware, Newark, DE 19713, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19476","DOI":"10.1074\/jbc.RA118.001934","article-title":"The Mucinous Domain of Pancreatic Carboxyl-Ester Lipase (CEL) Contains Core 1\/Core 2 O-Glycans That Can Be Modified by ABO Blood Group Determinants","volume":"293","author":"Johansson","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic Cancer","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"ref_4","unstructured":"American Cancer Society (2026, April 13). Key Statistics for Pancreatic Cancer. Available online: https:\/\/www.cancer.org\/cancer\/types\/pancreatic-cancer\/about\/key-statistics.html."},{"key":"ref_5","unstructured":"National Cancer Institute (2026, April 13). Cancer Stat Facts: Pancreatic Cancer, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jnci\/djaa004","article-title":"Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis","volume":"112","author":"Blackford","year":"2020","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1038\/s41467-023-38921-8","article-title":"Increased Glucose Availability Sensitizes Pancreatic Cancer to Chemotherapy","volume":"14","author":"Hue","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in Cancer Therapy: A Novel Approach to Reversing Drug Resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","article-title":"The Glutathione Redox System Is Essential to Prevent Ferroptosis Caused by Impaired Lipid Metabolism in Clear Cell Renal Cell Carcinoma","volume":"37","author":"Miess","year":"2018","journal-title":"Oncogene"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Waissi, W., Am\u00e9, J.-C., Mura, C., No\u00ebl, G., and Burckel, H. (2021). Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136825"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"BSR20200401","DOI":"10.1042\/BSR20200401","article-title":"Mechanisms of Drug Resistance of Pancreatic Ductal Adenocarcinoma at Different Levels","volume":"40","author":"Du","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/1878-0261.13279","article-title":"Systematic Exploration of the Underlying Mechanism of Gemcitabine Resistance in Pancreatic Adenocarcinoma","volume":"16","author":"Liu","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e2417625","DOI":"10.1001\/jamanetworkopen.2024.17625","article-title":"Pathological Complete Response in Patients with Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy","volume":"7","author":"Stoop","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12957-017-1240-2","article-title":"Neoadjuvant Treatment of Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis of 5520 Patients","volume":"15","author":"Dhir","year":"2017","journal-title":"World J. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1111\/cas.15962","article-title":"Increased Mitochondria Are Responsible for the Acquisition of Gemcitabine Resistance in Pancreatic Cancer Cell Lines","volume":"114","author":"Masuo","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_16","first-page":"10","article-title":"Cancer Statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1093\/nar\/gkh822","article-title":"Camptothecin Enhances the Frequency of Oligonucleotide-Directed Gene Repair in Mammalian Cells by Inducing DNA Damage and Activating Homologous Recombination","volume":"32","author":"Ferrara","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Issa, I.I., Due, H., Br\u00f8ndum, R.F., Veeravakaran, V., Haraldsd\u00f3ttir, H., Sylvester, C., Brogaard, A., Dhanjal, S., Schmierer, B., and Dybk\u00e6r, K. (2024). CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma. Cancers, 16.","DOI":"10.3390\/cancers16132437"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4161\/cc.7.10.5826","article-title":"DNA Replication, Cell Cycle Progression and the Targeted Gene Repair Reaction","volume":"7","author":"Engstrom","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11958","DOI":"10.1093\/nar\/gkaa975","article-title":"INDEL Detection, the \u2018Achilles Heel\u2019 of Precise Genome Editing: A Survey of Methods for Accurate Profiling of Gene Editing Induced Indels","volume":"48","author":"Bennett","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1038\/s41467-022-30480-8","article-title":"Cas9-Induced Large Deletions and Small Indels Are Controlled in a Convergent Fashion","volume":"13","author":"Kosicki","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s42003-019-0705-y","article-title":"Understanding the Diversity of Genetic Outcomes from CRISPR-Cas Generated Homology-Directed Repair","volume":"2","author":"Sansbury","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and Applications of CRISPR-Cas9 for Genome Engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","article-title":"CRISPR\/Cas9 Therapeutics: Progress and Prospects","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ravichandran, M., and Maddalo, D. (2023). Applications of CRISPR-Cas9 for Advancing Precision Medicine in Oncology: From Target Discovery to Disease Modeling. Front. Genet., 14.","DOI":"10.3389\/fgene.2023.1273994"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"201079","DOI":"10.1016\/j.omton.2025.201079","article-title":"Functional Characterization of Tumor-Specific CRISPR-Directed Gene Editing as a Combinatorial Therapy for the Treatment of Solid Tumors","volume":"33","author":"Banas","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"201122","DOI":"10.1016\/j.omton.2025.201122","article-title":"Target Choice and Exon Skipping Regulate CRISPR-Directed Gene Editing of NRF2 in Head\/Neck and Esophageal Cancer Cells","volume":"34","author":"Skelly","year":"2026","journal-title":"Mol. Ther. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.omto.2018.10.002","article-title":"Functional Gene Knockout of NRF2 Increases Chemosensitivity of Human Lung Cancer A549 Cells In Vitro and in a Xenograft Mouse Model","volume":"11","author":"Bialk","year":"2018","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41434-022-00324-7","article-title":"Exon Skipping Induced by CRISPR-Directed Gene Editing Regulates the Response to Chemotherapy in Non-Small Cell Lung Carcinoma Cells","volume":"29","author":"Banas","year":"2022","journal-title":"Gene Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cam4.2101","article-title":"Nrf2 in Cancers: A Double-Edged Sword","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-4598-10-37","article-title":"Nrf2 Is Overexpressed in Pancreatic Cancer: Implications for Cell Proliferation and Therapy","volume":"10","author":"Lister","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MPA.0b013e3181c31314","article-title":"Nuclear Factor (Erythroid-Derived 2)-Like 2 Regulates Drug Resistance in Pancreatic Cancer Cells","volume":"39","author":"Kang","year":"2010","journal-title":"Pancreas"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"He, F., Ru, X., and Wen, T. (2020). NRF2, a Transcription Factor for Stress Response and Beyond. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134777"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.wneu.2011.09.055","article-title":"The Dark Side of Nrf2","volume":"80","author":"Grossman","year":"2013","journal-title":"World Neurosurg."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Cykowiak, M., and Krajka-Ku\u017aniak, V. (2021). Role of Nrf2 in Pancreatic Cancer. Antioxidants, 11.","DOI":"10.3390\/antiox11010098"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1158\/0008-5472.CAN-19-1363","article-title":"Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers","volume":"80","author":"Mukhopadhyay","year":"2020","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2360427","DOI":"10.1155\/2018\/2360427","article-title":"Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway","volume":"2018","author":"Xiang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"114039","DOI":"10.1016\/j.biopha.2022.114039","article-title":"Periplocin Exerts Antitumor Activity by Regulating Nrf2-Mediated Signaling Pathway in Gemcitabine-Resistant Pancreatic Cancer Cells","volume":"157","author":"Bae","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e31416","DOI":"10.1002\/jcp.31416","article-title":"Nrf2-mediated Adenylosuccinate Lyase Promotes Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma Cells through Ferroptosis Escape","volume":"239","author":"Hsu","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"101131","DOI":"10.1016\/j.redox.2019.101131","article-title":"Digoxin Sensitizes Gemcitabine-Resistant Pancreatic Cancer Cells to Gemcitabine via Inhibiting Nrf2 Signaling Pathway","volume":"22","author":"Zhou","year":"2019","journal-title":"Redox Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","article-title":"Nrf2 Enhances Resistance of Cancer Cells to Chemotherapeutic Drugs, the Dark Side of Nrf2","volume":"29","author":"Wang","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ijc.2910150505","article-title":"Establishment of a Continuous Tumor-cell Line (PANC-1) from a Human Carcinoma of the Exocrine Pancreas","volume":"15","author":"Lieber","year":"1975","journal-title":"Int. J. Cancer"},{"key":"ref_43","first-page":"3747","article-title":"Mechanisms Underlying Gemcitabine Resistance in Pancreatic Cancer and Sensitisation by the IMiDTM Lenalidomide","volume":"31","author":"Fryer","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/crispr.2020.0022","article-title":"Deconvolution of Complex DNA Repair (DECODR): Establishing a Novel Deconvolution Algorithm for Comprehensive Analysis of CRISPR-Edited Sanger Sequencing Data","volume":"4","author":"Bloh","year":"2021","journal-title":"CRISPR J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00280-011-1722-9","article-title":"Nrf2 Knockdown by ShRNA Inhibits Tumor Growth and Increases Efficacy of Chemotherapy in Cervical Cancer","volume":"69","author":"Ma","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/jcb.30333","article-title":"Knockout of NRF2 Triggers Prostate Cancer Cells Death through ROS Modulation and Sensitizes to Cisplatin","volume":"123","author":"Mancini","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"169727","DOI":"10.1016\/j.scitotenv.2023.169727","article-title":"Nicotine Promotes Epithelial to Mesenchymal Transition and Gemcitabine Resistance via HENT1\/RRM1 Signalling in Pancreatic Cancer and Chemosensitizing Effects of Embelin-a Naturally Occurring Benzoquinone","volume":"914","author":"Prashanth","year":"2024","journal-title":"Sci. Total Environ."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: Homology Modelling of Protein Structures and Complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1002\/cmdc.202100458","article-title":"A Step toward NRF2-DNA Interaction Inhibitors by Fragment-Based NMR Methods","volume":"16","author":"Fuchs","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zimta, A.-A., Cenariu, D., Irimie, A., Magdo, L., Nabavi, S.M., Atanasov, A.G., and Berindan-Neagoe, I. (2019). The Role of Nrf2 Activity in Cancer Development and Progression. Cancers, 11.","DOI":"10.3390\/cancers11111755"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2337\/db13-0909","article-title":"Nrf2 Protects Pancreatic \u03b2-Cells from Oxidative and Nitrosative Stress in Diabetic Model Mice","volume":"63","author":"Yagishita","year":"2014","journal-title":"Diabetes"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/6\/828\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:51:57Z","timestamp":1780537917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/6\/828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["biom16060828"],"URL":"https:\/\/doi.org\/10.3390\/biom16060828","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}